Short communication
Myoclonic involuntary movement associated with chronic manganese poisoning

https://doi.org/10.1016/S0022-510X(02)00111-9Get rights and content

Abstract

We report a 17-year-old man showing myoclonic involuntary movement (IVM) associated with chronic manganese (Mn) poisoning. The patient, a welder, showed myoclonic IVM mainly in the right upper and lower extremities, elevated levels of Mn in the blood and hair and high-intensity signals in the globus pallidus on T1-weighted MR images. Chelation therapy resulted in improvement of the myoclonic IVM and MRI abnormalities. This is the first report of Mn poisoning characterized by myoclonic IVM without parkinsonism.

Introduction

The most characteristic manifestations of manganese (Mn) poisoning are extrapyramidal tract syndrome, primarily parkinsonism [2], [4], [7], [10]. We recently encountered a patient with chronic Mn poisoning due to electric arc welding, who showed myoclonic involuntary movement (IVM), but no parkinsonism.

Section snippets

Case report

The patient was a 17-year-old man with chief complaints of IVM of the right upper and lower extremities. His past or family history was not remarkable. He had been engaged in electric arc welding for about 2 years.

On February 14, 2000, the patient's right arm began to tremble while he was welding. The trembling subsided in about one hour. Thereafter, the patient became to frequently suffer from the trembling of the right arm and leg, and he stopped his work of welding. The drug therapies

Discussion

Our patient was characterized by myoclonic IVM mainly in the right upper and lower extremities, hyperintense globus pallidus on T1-weighted MR images, and elevated Mn levels in the blood and hair. The chelation therapy resulted in excretion of Mn in the urine, normalization of Mn levels in the blood and remarkable improvement of the myoclonic symptoms and MRI abnormalities. These findings indicate that the patient had been suffering from Mn poisoning and that the myoclonic IVM was associated

References (14)

There are more references available in the full text version of this article.

Cited by (71)

  • The impact of manganese on neurotransmitter systems

    2020, Journal of Trace Elements in Medicine and Biology
    Citation Excerpt :

    Humans are easily exposed to Mn through air, soil and, consequently, water, being the main source of intoxication identified due to occupational exposure [9,55]. Industry professionals in battery production, welding and mining operations are constantly exposed to Mn by inhalation, with reported neurotoxicity in these workers [27,56–59]. Neurological damage with Mn accumulation in various areas of the midbrain such as globus pallidus, substantia nigra, subthalamic nucleus, putamen, caudate nucleus and dentate nucleus has been described [31,60,61].

  • Ethanol increases manganese—Induced spatial learning and memory deficits via oxidative/nitrosative stress induced p53 dependent/independent hippocampal apoptosis

    2019, Toxicology
    Citation Excerpt :

    Early symptoms of Mn toxicity are compulsive behavior, emotional instability, slowing motor functions, intellectual and memory impairment (Mergler and Baldwin, 1997; Blecharz-Klin et al., 2012; Lucchini et al., 2012). Environmental and occupational exposure to Mn occurs mainly in Mn alloys mining, steel welding, smelters (Crossgrove and Zheng, 2004; Ono et al., 2002) and in the production of dye, paints, fertilizers, lacquers, fireworks, dry cell batteries, fungicides, wood preservatives and rubber (Blecharz-Klin et al., 2012) and other industries. It has been reported that Mn induced neurotoxicity involved diminished learning abilities and lower scores in many neurobehavioral tests (He et al., 1994; Zhang et al., 1995; Menezes-Filho et al., 2009).

  • Nonmotor Symptoms in Vascular and Other Secondary Parkinsonism

    2017, International Review of Neurobiology
    Citation Excerpt :

    The doses of Mn and exposure time that produce them are not precisely known (Jain & Ferrando, 2011; Sikk et al., 2011). Repeated courses of calcium and sodium EDTA that accelerates manganese excretion may cause regress of neurological symptoms (Herrero Hernandez et al., 2006; Ono et al., 2002). In patients with ephedrone encephalopathy, CaNa2EDTA decreases a probability of the further disease progress, though do not contribute significantly to symptoms regress (Levin, 2005; Selikhova et al., 2008).

View all citing articles on Scopus
View full text